U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 12.25 +0.18 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.07 | 52 Week High | $135.54 | |||
| Open | $12.13 | 52 Week Low | $94.36 | |||
| Day High | $12.34 | P/E | N/A | |||
| Day Low | $12.13 | EPS | $0.00 | |||
| Volume | 243,562 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 49.06 +1.06 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.00 | 52 Week High | $135.00 | |||
| Open | $48.00 | 52 Week Low | $94.95 | |||
| Day High | $49.06 | P/E | N/A | |||
| Day Low | $49.06 | EPS | $0.00 | |||
| Volume | 745 | |||||
